Dr Jonathan Chernoff, Fox Chase Cancer Center Director, Named Fellow of Scientific Society

Jonathan Chernoff, MD, PhD

Jonathan Chernoff, MD, PhD, Cancer Center Director at Fox Chase Cancer Center, has been named a Fellow of the American Society for Cell Biology (ASCB).

“Research in cell biology is such an integral part of my work in the fight against cancer,” said Chernoff. “I’m incredibly humbled to have the opportunity to represent the ASCB with this new honor.”

Fellowship in the ASCB is awarded based on the recipient’s significant contributions to the advancement of cell biology. Approximately 20 fellows are selected annually by their peers from the society’s 6,000 members. Chernoff will be recognized for this new honor at the opening session of the 2024 Cell Bio Meeting this December in San Diego.

A molecular oncologist and board-certified medical oncologist, Chernoff joined Fox Chase in 1991. In addition to helping define the strategic direction for Fox Chase research, he has made fundamental contributions in his own laboratory, which focuses on factors that control cell growth and movement, including oncogenes and anticancer or tumor-suppressor genes.

In addition to being Cancer Center Director, he also holds the Stanley P. Reimann Chair in Oncology Research and is a Professor in the Cancer Signaling and Microenvironment Research Program.

The ASCB is dedicated to scientific advancement and works to create a rich and multidisciplinary cell-centered community. Founded in 1960, the ASCB has evolved from a focus on electron microscopy to new technologies and discoveries. The ASCB includes members from undergraduates to practicing medical professionals and has included over 30 Nobel Prize recipients.

Chernoff received both his graduate and doctoral degrees in biochemistry from Mount Sinai School of Medicine in New York and his undergraduate degree in molecular biophysics and biochemistry from Yale University.

Throughout his career, Chernoff has earned a number of awards and recognitions, including being named a Fellow by the American Association for the Advancement of Science, membership in the Interurban Clinical Club, and receiving the Drug Discovery Award from the Pennsylvania Drug Discovery Institute.